ICL surgery is a vision correction procedure that is FDA approved to treat nearsightedness (myopia) and astigmatism in the United States. This is an artificial lens that is surgically implanted inside the eye. It is carefully placed between the iris, which is the colored part of the eye, and the natural lens. Unlike laser refractive surgery (LASIK and PRK) that treats the cornea on the outside of the eye, ICL surgery is intraocular surgery and therefore is performed in the sterile operating room to ensure maximum safety. Because the lens is placed inside the eye, it does not require daily replacement or cleaning like a regular contact lens.

ICL surgery has the advantage of delivering clear vision with a quick recovery and minimal discomfort. The procedure itself is done with plenty of numbing medicine as well as sedation through an IV to ensure patients are comfortable the entire time.

Who is a good candidate for ICL surgery?

• Ideally someone who is over 21 years old, when vision is more likely to have stopped changing, up to 45 years of age.
• A stable eye prescription that has not changed significantly over the last year.
• Your corneas are healthy.
• Your overall eye health is good.
• Your prescription has to be one that can safely be treated with ICL.
• Patients with slightly thin or corneas irregular corneas.
• Moderate to very high amounts of nearsightedness (myopia) and/or astigmatism.
• A family history of certain corneal disease.
• Patients with active lifestyles who desire a quick recovery.